[go: up one dir, main page]

AR038208A1 - Composicion farmaceutica dispersable oralmente de mitiglinida - Google Patents

Composicion farmaceutica dispersable oralmente de mitiglinida

Info

Publication number
AR038208A1
AR038208A1 ARP030100179A ARP030100179A AR038208A1 AR 038208 A1 AR038208 A1 AR 038208A1 AR P030100179 A ARP030100179 A AR P030100179A AR P030100179 A ARP030100179 A AR P030100179A AR 038208 A1 AR038208 A1 AR 038208A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical composition
ortially
mitiglinida
dispersable
mitiglinide
Prior art date
Application number
ARP030100179A
Other languages
English (en)
Inventor
Patrick Wuthrich
Herve Rolland
Marc Julien
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of AR038208A1 publication Critical patent/AR038208A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035—Isoindoles, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)

Abstract

Composición farmacéutica sólida dispersable oralmente de mitiglinida que contiene mitiglinida o una de sus sales farmacéuticamente aceptables, y gránulos que consisten en lactosa y almidón cosecados.
ARP030100179A 2002-01-23 2003-01-22 Composicion farmaceutica dispersable oralmente de mitiglinida AR038208A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0200794A FR2834892B1 (fr) 2002-01-23 2002-01-23 Composition pharmaceutique orodispersible de mitiglinide

Publications (1)

Publication Number Publication Date
AR038208A1 true AR038208A1 (es) 2005-01-05

Family

ID=27589558

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030100179A AR038208A1 (es) 2002-01-23 2003-01-22 Composicion farmaceutica dispersable oralmente de mitiglinida

Country Status (3)

Country Link
AR (1) AR038208A1 (es)
FR (1) FR2834892B1 (es)
WO (1) WO2003061650A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004002474A1 (ja) * 2002-06-28 2004-01-08 Kissei Pharmaceutical Co., Ltd. 糖尿病性合併症の予防又は進展阻止用医薬組成物
JP5237098B2 (ja) * 2006-08-08 2013-07-17 キッセイ薬品工業株式会社 苦味をマスキングした口腔内崩壊錠、およびその製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3506276C1 (de) * 1985-02-22 1986-04-24 Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring Direkttablettiermittel
TW391880B (en) * 1994-01-31 2000-06-01 Yamanouchi Pharma Co Ltd An oral soluble type compression moulding and its preparation
FR2765578B1 (fr) * 1997-07-03 1999-09-10 Adir Procede de preparation d'un perhydroisoindole substitue
ES2292414T3 (es) * 2000-07-27 2008-03-16 Roquette Freres Granulos a base de almidon y de lactosa.

Also Published As

Publication number Publication date
WO2003061650A1 (fr) 2003-07-31
FR2834892B1 (fr) 2004-02-27
FR2834892A1 (fr) 2003-07-25

Similar Documents

Publication Publication Date Title
AR038207A1 (es) Composicion farmaceutica dispersable oralmente de agomelatina
NO20052855D0 (no) Fosfonoksykinazolinderivater og farmasoytisk anvendelse derav.
NO20024891L (no) Farmasöytiske sammensetninger
NO20045434L (no) En kombinasjon av en NMDA-antagonist og acetylkolinesteraseinhibitorer for behandlingen av Alzheimers sykdom
EP1587474A3 (en) Fluoroalkoxy-substituted 1, 3-dihydro-isoindolyl compounds and their pharmaceutical uses
ZA200501677B (en) Hydantoin derivatives and their use as TACE inhibitors.
CL2004001174A1 (es) Composicion farmaceutica que comprende: 1-(4-fluorofenil)-3(r)-[3-(4-fluorofenil)-3(s)-hidroxipropil]-4(s)-(4-hidroxifenil)-2-acetidinona (ezetimiba) y excipientes; y su uso en el tratamiento y/o prevencion de aterosclerosis, hipercolesterolemia, dia
NO20052469D0 (no) Inhibitorer av II-beta-hydroksysteroid-dehydrogenase type 1 og type 2.
IL152916A0 (en) Heteroaryl-phenyl heterobicyclic factor xa inhibitors
LU92513I2 (fr) Sofosbuvir et ses dérivés pharmaceutiquement acceptables (solvaldi)
NO20042161L (no) Inhibitorer av 11-beta-hydroksysteroid dehydrogenase type 1
NO20024528L (no) Proteaseinhibitor, farmasoytisk sammensetning og anvendelse av forbindelsen
EE200300212A (et) Ravimite kombinatsioonid (näiteks kloorpromasiin ja pentamidiin) neoplastiliste haiguste raviks
WO2004037176A3 (en) Quinazolinones and derivatives thereof as factor xa inhibitors
NO20053356D0 (no) Aminindazolderivater og anvendelse derav som kinaseinhibitorer.
EE200300311A (et) Ftalasinoon-piperidinoderivaadid, nende kasutamine ja ravim
DE60209929D1 (de) Succinate des 5,8,14-triazatetracycloä10.3.1.0 2,11 .0 4,9 ü-hexadeca-2(11),3,5,7,9,-pentaens und pharmazeutische zusammensetzungen
AR038206A1 (es) Composicion farmaceutica dispersable oralmente de ivabradina
SE0101932D0 (sv) Pharmaceutical combinations
WO2005007137A3 (de) Ambroxolhaltige tabletten
AR038305A1 (es) Composicion farmaceutica dispersable oralmente de perindopril
AR033467A1 (es) Comprimido de meloxicam de rapida disgregacion
NO2010004I1 (no) 0,02 mg etinylostradiol (som betadexclathrat) og 3mg drospirenon
DK1202996T3 (da) Titanforbindelser, fremstilling og anvendelse heraf
DK1523473T3 (da) Indolinderivater substitueret i position 6, deres fremstilling og anvendelse som lægemiddel.

Legal Events

Date Code Title Description
FB Suspension of granting procedure